Literature DB >> 27497847

Outcomes of pre-emptive and rescue use of percutaneous left ventricular assist device in patients with structural heart disease undergoing catheter ablation of ventricular tachycardia.

Nilesh Mathuria1, Geru Wu2, Francia Rojas-Delgado2, Mossaab Shuraih2, Mehdi Razavi2, Andrew Civitello2, Leo Simpson2, Guilherme Silva2, Suwei Wang3, MacArthur Elayda3, Bharat Kantharia4, Steve Singh5, O H Frazier5, Jie Cheng2.   

Abstract

PURPOSE: Patient selection and timing of percutaneous left ventricular assist device (pLVAD) insertion for maximal benefit during ventricular tachycardia (VT) ablation is not well defined. We aimed to assess the outcomes of pre-emptive and rescue use of pLVAD during VT ablation in patients with ischemic and non-ischemic cardiomyopathy.
METHODS: Between January 2009 and October 2011, 93 patients underwent VT ablation. Three groups were compared: (1) Rescue group (n = 12)-patients who required emergent pLVAD insertion due to hemodynamic collapse during VT ablation, (2) Pre-emptive group (n = 24)-patients who had pre-ablation pLVAD insertion, and (3) Non-pLVAD group (n = 57)-patients who did not undergo pLVAD insertion. Procedural outcomes including 30-day mortality were compared.
RESULTS: Thirty-day mortality was higher in the Rescue group compared to the Pre-emptive group (58 vs. 4 %, p = 0.003) and non-pLVAD (58 vs. 3 %, p = 0.001) group. There was no significant difference in 30-day mortality or long-term freedom of VT between the pre-emptive and non-pLVAD groups.
CONCLUSIONS: Despite rescue pLVAD insertion, hemodynamic collapse during VT ablation is associated with a persistently high 30-day mortality. Further studies are warranted to predict hemodynamic collapse and to refine the role of pLVAD in this setting.

Entities:  

Keywords:  Ablation; Cardiomyopathy; Percutaneous left ventricular assist device; Ventricular tachycardia

Mesh:

Year:  2016        PMID: 27497847     DOI: 10.1007/s10840-016-0168-8

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  21 in total

1.  The percutaneous ventricular assist device in severe refractory cardiogenic shock.

Authors:  Biswajit Kar; Igor D Gregoric; Sukhdeep S Basra; Gary M Idelchik; Pranav Loyalka
Journal:  J Am Coll Cardiol       Date:  2010-10-14       Impact factor: 24.094

2.  Percutaneous endocardial and epicardial ablation of hypotensive ventricular tachycardia with percutaneous left ventricular assist in the electrophysiology laboratory.

Authors:  Paul A Friedman; Thomas M Munger; Norman Torres; Charanjit Rihal
Journal:  J Cardiovasc Electrophysiol       Date:  2007-01

Review 3.  Percutaneous left ventricular assist devices during cardiogenic shock and high-risk percutaneous coronary interventions.

Authors:  Stéphane Cook; Stephan Windecker
Journal:  Curr Cardiol Rep       Date:  2009-09       Impact factor: 2.931

4.  Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study.

Authors:  Roderick Tung; Marmar Vaseghi; David S Frankel; Pasquale Vergara; Luigi Di Biase; Koichi Nagashima; Ricky Yu; Sitaram Vangala; Chi-Hong Tseng; Eue-Keun Choi; Shaan Khurshid; Mehul Patel; Nilesh Mathuria; Shiro Nakahara; Wendy S Tzou; William H Sauer; Kairav Vakil; Usha Tedrow; J David Burkhardt; Venkatakrishna N Tholakanahalli; Anastasios Saliaris; Timm Dickfeld; J Peter Weiss; T Jared Bunch; Madhu Reddy; Arun Kanmanthareddy; David J Callans; Dhanunjaya Lakkireddy; Andrea Natale; Francis Marchlinski; William G Stevenson; Paolo Della Bella; Kalyanam Shivkumar
Journal:  Heart Rhythm       Date:  2015-05-30       Impact factor: 6.343

Review 5.  Current status of percutaneous ventricular assist devices for cardiogenic shock.

Authors:  Sukhdeep S Basra; Pranav Loyalka; Biswajit Kar
Journal:  Curr Opin Cardiol       Date:  2011-11       Impact factor: 2.161

6.  A new technique to perform epicardial mapping in the electrophysiology laboratory.

Authors:  E Sosa; M Scanavacca; A d'Avila; F Pilleggi
Journal:  J Cardiovasc Electrophysiol       Date:  1996-06

7.  Catheter ablation of recurrent scar-related ventricular tachycardia using electroanatomical mapping and irrigated ablation technology: results of the prospective multicenter Euro-VT-study.

Authors:  Hildegard Tanner; Gerhard Hindricks; Marius Volkmer; Steve Furniss; Volker Kühlkamp; Dominique Lacroix; Christian DE Chillou; Jesús Almendral; Domenico Caponi; Karl-Heinz Kuck; Hans Kottkamp
Journal:  J Cardiovasc Electrophysiol       Date:  2009-07-28

Review 8.  Ablation of ventricular tachycardia in patients with structural heart disease.

Authors:  Katja Zeppenfeld; William G Stevenson
Journal:  Pacing Clin Electrophysiol       Date:  2008-03       Impact factor: 1.976

9.  A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience.

Authors:  Simon R Dixon; José P S Henriques; Laura Mauri; Krischan Sjauw; Andrew Civitello; Biswajit Kar; Pranav Loyalka; Frederic S Resnic; Paul Teirstein; Raj Makkar; Igor F Palacios; Michael Collins; Jeffrey Moses; Karim Benali; William W O'Neill
Journal:  JACC Cardiovasc Interv       Date:  2009-02       Impact factor: 11.195

10.  Use of the Impella microaxial blood pump for ablation of hemodynamically unstable ventricular tachycardia.

Authors:  Hussam Abuissa; John Roshan; Bernard Lim; Samuel J Asirvatham
Journal:  J Cardiovasc Electrophysiol       Date:  2009-12-21
View more
  10 in total

1.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Saenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  J Interv Card Electrophysiol       Date:  2020-10       Impact factor: 1.900

2.  Prophylactic mechanical hemodynamic support for catheter ablation of VT: locking the barn door before the horse has bolted.

Authors:  Pasquale Santangeli; Luigi Di Biase
Journal:  J Interv Card Electrophysiol       Date:  2016-11-25       Impact factor: 1.900

Review 3.  Extracorporeal life support for refractory ventricular tachycardia.

Authors:  Sujatha P Bhandary; Nicholas Joseph; James P Hofmann; Theodosios Saranteas; Thomas J Papadimos
Journal:  Ann Transl Med       Date:  2017-02

4.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Sáenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  Europace       Date:  2019-08-01       Impact factor: 5.214

5.  Multidisciplinary Approach to Hemodynamic Management During High-Risk Ventricular Tachycardia Ablation.

Authors:  Aditya Bharadwaj; Melissa D McCabe; Tahmeed Contractor; Hyungjin Ben Kim; Antoine Sakr; Anthony Hilliard; Ravi Mandapati; Rahul Bhardwaj
Journal:  JACC Case Rep       Date:  2022-06-01

Review 6.  Management of ventricular tachycardia storm in patients with structural heart disease.

Authors:  Daniele Muser; Pasquale Santangeli; Jackson J Liang
Journal:  World J Cardiol       Date:  2017-06-26

Review 7.  Electrical Storm in Patients with Implantable Cardioverter-defibrillators: A Practical Overview.

Authors:  Daniele Muser; Jackson J Liang; Pasquale Santangeli
Journal:  J Innov Card Rhythm Manag       Date:  2017-10-15

8.  Management of ventricular arrhythmias in heart failure: Current perspectives.

Authors:  Petr Peichl; Adam Rafaj; Josef Kautzner
Journal:  Heart Rhythm O2       Date:  2021-12-17

9.  Percutaneous right ventricular assist device-supported ventricular tachycardia ablation in a patient with severe right ventricular dysfunction.

Authors:  Martin Aguilar; Allison L Tsao; Kevin J Croce; William Sauer; David A Morrow; Usha B Tedrow
Journal:  HeartRhythm Case Rep       Date:  2019-11-04

10.  Complications and mortality after catheter ablation of ventricular arrhythmias: risk in VT ablation (RIVA) score.

Authors:  Shibu Mathew; Thomas Fink; Sebastian Feickert; Osamu Inaba; Naotaka Hashiguchi; Michael Schlüter; Peter Wohlmuth; Erik Wissner; Roland Richard Tilz; Christian-Hendrik Heeger; Laura Rottner; Bruno Reissmann; Andreas Rillig; Andreas Metzner; Tilman Maurer; Karl-Heinz Kuck; Feifan Ouyang
Journal:  Clin Res Cardiol       Date:  2021-07-27       Impact factor: 6.138

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.